StockData
Protagonist Therapeutics, Inc logo

Protagonist Therapeutics, Inc (PTGX) stock

PTGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/30199% above fair value
$127.16+2.49 (+2.00%)

Close on Nov 18, 2026Market cap $8.23BP/E 123.5Yield –

Protagonist Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Protagonist Therapeutics's market cap was $8.72B on Nov 11, 2026, against $5.62B a year earlier. Over the last 5 years it ranged from $384.05M to $9.56B, with a median of $2.03B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$8.72B+59.9%
2025Dec 31, 2025$5.45B+137.4%
2024Dec 31, 2024$2.30B+73.8%
2023Dec 29, 2023$1.32B+146.3%
2022Dec 30, 2022$536.75M-67.1%
2021Dec 31, 2021$1.63B+116.7%
2020Dec 31, 2020$752.27M+292.2%
2019Dec 31, 2019$191.81M+18.1%
2018Dec 31, 2018$162.45M-53.9%
2017Dec 29, 2017$352.44M-4.1%
2016Dec 30, 2016$367.55M–

More Protagonist Therapeutics figures

See a number that looks wrong?